ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Iopamidol Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38L10018
Home | Market Reports | Health| Pharmacy
Global Iopamidol Injection Market Insights Forecast to 2028
BUY CHAPTERS

Global Iopamidol Injection Market Research Report 2025

Code: QYRE-Auto-38L10018
Report
July 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bracco Imaging
Sanochemia
BeiLu Pharma

Iopamidol Injection Market Size

The global market for Iopamidol Injection was valued at US$ 890 million in the year 2024 and is projected to reach a revised size of US$ 1016 million by 2031, growing at a CAGR of 1.9% during the forecast period.

Iopamidol Injection Market

Iopamidol Injection Market

Iopamidol injection is a non-ionic, water-soluble contrast agent commonly used in diagnostic imaging procedures such as computed tomography (CT) scans, angiography, and urography to improve the visibility of blood vessels, organs, and tissues by providing contrast enhancement for accurate visualization and interpretation of medical images.
Market Drivers:
Diagnostic Clarity: Iopamidol injection enhances the clarity and quality of diagnostic images by providing excellent contrast enhancement, tissue delineation, and visualization of anatomical structures, aiding healthcare professionals in making accurate diagnoses, treatment planning, and monitoring of medical conditions.
Renal Safety: With a lower risk of causing contrast-induced nephropathy (CIN) and renal injury compared to some other contrast agents, iopamidol is considered a safer option for patients with compromised renal function or those at higher risk of kidney complications following contrast-enhanced imaging studies.
Versatility in Imaging: Iopamidol injection is versatile and widely used in various radiological imaging modalities, including CT scans, angiography, urography, and vascular interventions, making it a preferred choice across medical specialties such as radiology, cardiology, interventional radiology, and urology for diagnostic and interventional procedures.
Patient Comfort: Continuous improvements in iopamidol formulations focus on enhancing patient comfort and safety during imaging procedures, with developments in low-osmolality contrast agents, reduced injection volumes, and improved tolerability contributing to a better overall patient experience in diagnostic imaging studies.
Technological Advancements: Ongoing research and development efforts aim to optimize the formulation of iopamidol injection, improve image acquisition protocols, and enhance imaging equipment capabilities to deliver high-quality diagnostic images with reduced artifacts, improved spatial resolution, and enhanced diagnostic information.
Market Challenges:
Cost Constraints: The cost of iopamidol injection and associated imaging procedures can be a significant factor affecting its adoption, accessibility, and affordability for healthcare facilities, patients, and healthcare systems, particularly in the context of budget constraints and reimbursement limitations.
Competitive Landscape: The contrast media market is competitive, with multiple manufacturers offering a range of contrast agents, including iopamidol, leading to pricing pressures, market saturation, and challenges in differentiating products based on efficacy, safety, and cost-effectiveness to gain market share.
Regulatory Compliance: Manufacturers of iopamidol injection must adhere to stringent regulatory requirements, quality standards, and safety guidelines for contrast media production, labeling, and distribution to ensure product quality, consistency, and compliance with regulatory approvals for market entry.
Patient Factors: Variability in patient factors such as allergies, renal function, comorbidities, and medication history can influence the choice of contrast agents, dosing considerations, and risk assessment for iopamidol injection, necessitating personalized approaches to patient care and contrast administration.
Adverse Events Management: Despite its favorable safety profile, iopamidol injection can still lead to adverse reactions such as hypersensitivity responses, nephrotoxicity, and rare but serious side effects, requiring vigilant monitoring, prompt recognition, and appropriate management of adverse events during and after imaging procedures.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Iopamidol Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iopamidol Injection.
The Iopamidol Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Iopamidol Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iopamidol Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Iopamidol Injection Market Report

Report Metric Details
Report Name Iopamidol Injection Market
Accounted market size in year US$ 890 million
Forecasted market size in 2031 US$ 1016 million
CAGR 1.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 9 g I/ 30 mL
  • 11.1 g I/ 30 mL
  • Others
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bracco Imaging, Sanochemia, BeiLu Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Iopamidol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Iopamidol Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Iopamidol Injection Market growing?

Ans: The Iopamidol Injection Market witnessing a CAGR of 1.9% during the forecast period 2025-2031.

What is the Iopamidol Injection Market size in 2031?

Ans: The Iopamidol Injection Market size in 2031 will be US$ 1016 million.

Who are the main players in the Iopamidol Injection Market report?

Ans: The main players in the Iopamidol Injection Market are Bracco Imaging, Sanochemia, BeiLu Pharma

What are the Application segmentation covered in the Iopamidol Injection Market report?

Ans: The Applications covered in the Iopamidol Injection Market report are Hospitals, Clinics

What are the Type segmentation covered in the Iopamidol Injection Market report?

Ans: The Types covered in the Iopamidol Injection Market report are 9 g I/ 30 mL, 11.1 g I/ 30 mL, Others

Recommended Reports

Contrast Media Markets

Imaging Equipment

Contrast Injector Devices

1 Iopamidol Injection Market Overview
1.1 Product Definition
1.2 Iopamidol Injection by Type
1.2.1 Global Iopamidol Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 9 g I/ 30 mL
1.2.3 11.1 g I/ 30 mL
1.2.4 Others
1.3 Iopamidol Injection by Application
1.3.1 Global Iopamidol Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Iopamidol Injection Market Size Estimates and Forecasts
1.4.1 Global Iopamidol Injection Revenue 2020-2031
1.4.2 Global Iopamidol Injection Sales 2020-2031
1.4.3 Global Iopamidol Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Iopamidol Injection Market Competition by Manufacturers
2.1 Global Iopamidol Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Iopamidol Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Iopamidol Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Iopamidol Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Iopamidol Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Iopamidol Injection, Product Type & Application
2.7 Global Key Manufacturers of Iopamidol Injection, Date of Enter into This Industry
2.8 Global Iopamidol Injection Market Competitive Situation and Trends
2.8.1 Global Iopamidol Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Iopamidol Injection Players Market Share by Revenue
2.8.3 Global Iopamidol Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Iopamidol Injection Market Scenario by Region
3.1 Global Iopamidol Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Iopamidol Injection Sales by Region: 2020-2031
3.2.1 Global Iopamidol Injection Sales by Region: 2020-2025
3.2.2 Global Iopamidol Injection Sales by Region: 2026-2031
3.3 Global Iopamidol Injection Revenue by Region: 2020-2031
3.3.1 Global Iopamidol Injection Revenue by Region: 2020-2025
3.3.2 Global Iopamidol Injection Revenue by Region: 2026-2031
3.4 North America Iopamidol Injection Market Facts & Figures by Country
3.4.1 North America Iopamidol Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Iopamidol Injection Sales by Country (2020-2031)
3.4.3 North America Iopamidol Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Iopamidol Injection Market Facts & Figures by Country
3.5.1 Europe Iopamidol Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Iopamidol Injection Sales by Country (2020-2031)
3.5.3 Europe Iopamidol Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Iopamidol Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Iopamidol Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Iopamidol Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Iopamidol Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Iopamidol Injection Market Facts & Figures by Country
3.7.1 Latin America Iopamidol Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Iopamidol Injection Sales by Country (2020-2031)
3.7.3 Latin America Iopamidol Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Iopamidol Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Iopamidol Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Iopamidol Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Iopamidol Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Iopamidol Injection Sales by Type (2020-2031)
4.1.1 Global Iopamidol Injection Sales by Type (2020-2025)
4.1.2 Global Iopamidol Injection Sales by Type (2026-2031)
4.1.3 Global Iopamidol Injection Sales Market Share by Type (2020-2031)
4.2 Global Iopamidol Injection Revenue by Type (2020-2031)
4.2.1 Global Iopamidol Injection Revenue by Type (2020-2025)
4.2.2 Global Iopamidol Injection Revenue by Type (2026-2031)
4.2.3 Global Iopamidol Injection Revenue Market Share by Type (2020-2031)
4.3 Global Iopamidol Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Iopamidol Injection Sales by Application (2020-2031)
5.1.1 Global Iopamidol Injection Sales by Application (2020-2025)
5.1.2 Global Iopamidol Injection Sales by Application (2026-2031)
5.1.3 Global Iopamidol Injection Sales Market Share by Application (2020-2031)
5.2 Global Iopamidol Injection Revenue by Application (2020-2031)
5.2.1 Global Iopamidol Injection Revenue by Application (2020-2025)
5.2.2 Global Iopamidol Injection Revenue by Application (2026-2031)
5.2.3 Global Iopamidol Injection Revenue Market Share by Application (2020-2031)
5.3 Global Iopamidol Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bracco Imaging
6.1.1 Bracco Imaging Company Information
6.1.2 Bracco Imaging Description and Business Overview
6.1.3 Bracco Imaging Iopamidol Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bracco Imaging Iopamidol Injection Product Portfolio
6.1.5 Bracco Imaging Recent Developments/Updates
6.2 Sanochemia
6.2.1 Sanochemia Company Information
6.2.2 Sanochemia Description and Business Overview
6.2.3 Sanochemia Iopamidol Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanochemia Iopamidol Injection Product Portfolio
6.2.5 Sanochemia Recent Developments/Updates
6.3 BeiLu Pharma
6.3.1 BeiLu Pharma Company Information
6.3.2 BeiLu Pharma Description and Business Overview
6.3.3 BeiLu Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BeiLu Pharma Iopamidol Injection Product Portfolio
6.3.5 BeiLu Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Iopamidol Injection Industry Chain Analysis
7.2 Iopamidol Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Iopamidol Injection Production Mode & Process Analysis
7.4 Iopamidol Injection Sales and Marketing
7.4.1 Iopamidol Injection Sales Channels
7.4.2 Iopamidol Injection Distributors
7.5 Iopamidol Injection Customer Analysis
8 Iopamidol Injection Market Dynamics
8.1 Iopamidol Injection Industry Trends
8.2 Iopamidol Injection Market Drivers
8.3 Iopamidol Injection Market Challenges
8.4 Iopamidol Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bracco Imaging
Sanochemia
BeiLu Pharma
List of Tables
 Table 1. Global Iopamidol Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Iopamidol Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Iopamidol Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Iopamidol Injection Sales (K L) of Key Manufacturers (2020-2025)
 Table 5. Global Iopamidol Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Iopamidol Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Iopamidol Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Iopamidol Injection Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Iopamidol Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Iopamidol Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Iopamidol Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Iopamidol Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Iopamidol Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iopamidol Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Iopamidol Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Iopamidol Injection Sales by Region (2020-2025) & (K L)
 Table 18. Global Iopamidol Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Iopamidol Injection Sales by Region (2026-2031) & (K L)
 Table 20. Global Iopamidol Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Iopamidol Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Iopamidol Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Iopamidol Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Iopamidol Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Iopamidol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Iopamidol Injection Sales by Country (2020-2025) & (K L)
 Table 27. North America Iopamidol Injection Sales by Country (2026-2031) & (K L)
 Table 28. North America Iopamidol Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Iopamidol Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Iopamidol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Iopamidol Injection Sales by Country (2020-2025) & (K L)
 Table 32. Europe Iopamidol Injection Sales by Country (2026-2031) & (K L)
 Table 33. Europe Iopamidol Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Iopamidol Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Iopamidol Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Iopamidol Injection Sales by Region (2020-2025) & (K L)
 Table 37. Asia Pacific Iopamidol Injection Sales by Region (2026-2031) & (K L)
 Table 38. Asia Pacific Iopamidol Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Iopamidol Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Iopamidol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Iopamidol Injection Sales by Country (2020-2025) & (K L)
 Table 42. Latin America Iopamidol Injection Sales by Country (2026-2031) & (K L)
 Table 43. Latin America Iopamidol Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Iopamidol Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Iopamidol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Iopamidol Injection Sales by Country (2020-2025) & (K L)
 Table 47. Middle East and Africa Iopamidol Injection Sales by Country (2026-2031) & (K L)
 Table 48. Middle East and Africa Iopamidol Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Iopamidol Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Iopamidol Injection Sales (K L) by Type (2020-2025)
 Table 51. Global Iopamidol Injection Sales (K L) by Type (2026-2031)
 Table 52. Global Iopamidol Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Iopamidol Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Iopamidol Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Iopamidol Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Iopamidol Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Iopamidol Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Iopamidol Injection Price (US$/L) by Type (2020-2025)
 Table 59. Global Iopamidol Injection Price (US$/L) by Type (2026-2031)
 Table 60. Global Iopamidol Injection Sales (K L) by Application (2020-2025)
 Table 61. Global Iopamidol Injection Sales (K L) by Application (2026-2031)
 Table 62. Global Iopamidol Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Iopamidol Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Iopamidol Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Iopamidol Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Iopamidol Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Iopamidol Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Iopamidol Injection Price (US$/L) by Application (2020-2025)
 Table 69. Global Iopamidol Injection Price (US$/L) by Application (2026-2031)
 Table 70. Bracco Imaging Company Information
 Table 71. Bracco Imaging Description and Business Overview
 Table 72. Bracco Imaging Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 73. Bracco Imaging Iopamidol Injection Product
 Table 74. Bracco Imaging Recent Developments/Updates
 Table 75. Sanochemia Company Information
 Table 76. Sanochemia Description and Business Overview
 Table 77. Sanochemia Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 78. Sanochemia Iopamidol Injection Product
 Table 79. Sanochemia Recent Developments/Updates
 Table 80. BeiLu Pharma Company Information
 Table 81. BeiLu Pharma Description and Business Overview
 Table 82. BeiLu Pharma Iopamidol Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 83. BeiLu Pharma Iopamidol Injection Product
 Table 84. BeiLu Pharma Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Iopamidol Injection Distributors List
 Table 88. Iopamidol Injection Customers List
 Table 89. Iopamidol Injection Market Trends
 Table 90. Iopamidol Injection Market Drivers
 Table 91. Iopamidol Injection Market Challenges
 Table 92. Iopamidol Injection Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Iopamidol Injection
 Figure 2. Global Iopamidol Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Iopamidol Injection Market Share by Type: 2024 & 2031
 Figure 4. 9 g I/ 30 mL Product Picture
 Figure 5. 11.1 g I/ 30 mL Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Iopamidol Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Iopamidol Injection Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Global Iopamidol Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Iopamidol Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Iopamidol Injection Sales (2020-2031) & (K L)
 Figure 14. Global Iopamidol Injection Average Price (US$/L) & (2020-2031)
 Figure 15. Iopamidol Injection Report Years Considered
 Figure 16. Iopamidol Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Iopamidol Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Iopamidol Injection Players: Market Share by Revenue in Iopamidol Injection in 2024
 Figure 19. Iopamidol Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Iopamidol Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Iopamidol Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Iopamidol Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Iopamidol Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Iopamidol Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Iopamidol Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Iopamidol Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Iopamidol Injection Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Iopamidol Injection Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Iopamidol Injection Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Iopamidol Injection Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Iopamidol Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Iopamidol Injection by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Iopamidol Injection by Type (2020-2031)
 Figure 55. Global Iopamidol Injection Price (US$/L) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Iopamidol Injection by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Iopamidol Injection by Application (2020-2031)
 Figure 58. Global Iopamidol Injection Price (US$/L) by Application (2020-2031)
 Figure 59. Iopamidol Injection Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Iohexol Injection Market Research Report 2024
Global Iodixanol Injection Market Research Report 2024
Global Iopamidol API Market Research Report 2025
Global Industrial Solid Iohexol Market Research Report 2024
Global Non ionic Iodine Contrast Media Market Research Report 2024
Global Iodinated Contrast Media ICM Market Research Report 2024
Global Iodine Contrast Media Market Research Report 2025
Global Medical Contrast Media Injectors Market Insights Forecast to 2030
Global Organic Iodide Contrast Media Market Research Report 2025
Global Non iodinated X ray Contrast Agents Market Research Report 2024
Global Contrast Media Injector Market Insights Forecast to 2030
Iodinated Contrast Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ioxanol Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DSA Contrast Media Injector Market Research Report 2024
Global Iopromide API Market Research Report 2025
Global Dual Head Contrast Media Injector Market Research Report 2024
Iodine Formulations Contrast Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Iodine Contrast Agent Intermediate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contrast Media Injector in Vascular Market Research Report 2025
CT Contrast Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions